GREENVILLE, S.C. (WYFF/WIS) - CVS Health will begin to administer COVID-19 vaccines to eligible populations on Thursday, Feb. 11 at 17 CVS Pharmacy locations across South Carolina.
Appointments will become available for booking as early as Feb. 9 as stores receive shipments of vaccine, CVS said. However, there are some appointments already available in Camden.
Supply for the limited rollout in the state, which is sourced directly from the federal pharmacy partnership program, will be approximately 15,300 total doses.
Participating CVS Pharmacies are in communities throughout South Carolina, including Aiken, Anderson, Camden, Clemson, Columbia, Greenville, Myrtle Beach, Summerville, and Sumter.
As more supply becomes available, the company said it will expand to more locations and offer additional appointments.
“One of our greatest strengths as a company is our presence in communities across the country, which makes us an ideal partner for administering vaccines in a safe, convenient, and familiar manner,” said Karen S. Lynch, President and Chief Executive Officer, CVS Health. “We continue to be grateful for the commitment of our frontline colleagues whose dedication has allowed us to deliver care and peace of mind throughout the pandemic.”
Vaccines at participating CVS Pharmacy locations in South Carolina will only be available to individuals who fall under current DHEC guidelines for vaccine eligibility. To see what those are, click or tap here.
Patients must register in advance at CVS.com or through the CVS Pharmacy app, and people without online access can contact CVS customer service: (800) 746-7287.
Walk-in vaccinations without an appointment will not be provided.
The availability of COVID-19 vaccines in South Carolina is part of an initial 11-state rollout and includes approximately 335 CVS Pharmacy locations across California, Connecticut, Hawaii, Massachusetts, Maryland, New Jersey, New York, Rhode Island, Texas, and Virginia. Vaccines will eventually be available at CVS Pharmacy locations throughout the country subject to product availability, with the capacity to administer 20 to 25 million shots per month.